In vivo dosimetry for patients with prostate cancer to assess possible impact of bladder and rectum preparation. (December 2020)

• Record Type: Journal Article
• Authors: Fiagan, Yawo A.C.; Bossuyt, Evy; Nevens, Daan; Dirix, Piet; Theys, Frank; Gevaert, Thierry; Verellen, Dirk
• Is Part Of: Technical innovations & patient support in radiation oncology. Volume 16(2020)
• Page Start: 65
• Page End: 69
• Publication Date: 2020-12
• Subjects: Automated treatment delivery verification -- In vivo dosimetry -- Prostate cancer; Radiotherapy -- Periodicals; Cancer -- Radiotherapy -- Periodicals; Cancer -- Patients -- Hospital care -- Periodicals; 615.842
• DOI: 10.1016/j.tipsro.2020.10.005
• Languages: English
• ISSNs: 2405-6324

Abstract

Abstract: Purpose/objective: In all treatment sites of our radiotherapy network, in vivo dosimetry (PerFRACTION™) was fully implemented in February 2018. We hypothesized that additional help with bladder and rectum preparation by home nursing would improve patients' preparation and investigated if this could be assessed using in vivo dosimetry (IVD). Materials/methods: A retrospective study was conducted with a test group who received additional help with bladder and rectum preparation by home nurses and a control group who only received information on bladder and rectum preparation according to the standard protocol. Patients were treated with a 6 MV Volumetric Modulated Arc Therapy (VMAT) technique. Electronic portal imaging device (EPID)-based integrated transit dose images were acquired on the first 3 days of treatment and weekly thereafter or more if failed fractions (FF) occurred. Results were analyzed using a global gamma analysis with a threshold of 20%, tolerance of 5% (dose difference) and 5 mm (distance to agreement), and a passing level of 95%. Results: Data of 462 prostate patients was analyzed: 39 and 423 in a test and control group respectively with a comparable number of measurements (on average 8.0 (σ = 4.8) and 7.1 (σ = 4.5) respectively per treatment course). Of the FF, 39% and 31% were related to variations in bladder and rectum filling for the test and control group respectively. Subgroups were created based on the number of FF, no statistically significant differences were observed. Conclusion: Two dimensional EPID-based IVD successfully detected deviations due to variations in bladder and rectum filling, however it could not confirm the hypothesis.